TY - JOUR
T1 - Clinical islet transplantation in Japan
AU - Kenmochi, Takashi
AU - Asano, Takehide
AU - Maruyama, Michihiro
AU - Saigo, Kenichi
AU - Akutsu, Naotake
AU - Iwashita, Chikara
AU - Ohtsuki, Kazunori
AU - Ito, Taihei
N1 - Copyright:
Copyright 2009 Elsevier B.V., All rights reserved.
PY - 2009
Y1 - 2009
N2 - Introduction: The results of clinical islet transplantation in Japan are, here in, reported and discussed its efficacy and problems. Methods: Since the first islet transplantation was performed in 2004, 65 islet isolations and 34 islet transplantations to 18 type 1 diabetic patients have been performed in Japan. Results: Following islet transplantation, patients experienced decreased insulin requirements and lower hemoglobin A1C levels, and positive serum C-peptide levels. All patients achieved stabilized blood glucose levels and the disappearance of hypoglycemic unawareness. Although three patients achieved insulin independency for a limited period, persistent islet graft function was difficult to maintain. Overall islet graft survival was 86.5% at 6 months, 78.7% at 1 year, and 62.9% at 2 years after the first islet transplantation. In our institution, we carried out 23 islet isolations and six islet transplantations to four patients. Although insulin independency was not achieved, all patients showed a disappearance of hypoglycemic unawareness. Conclusions: Using data from the Japanese Trial of Islet Transplantation, the effectiveness of islet transplantation was shown even when using the pancreata from non-heart-beating donors. Although there are a number of problems to be solved and further improvement is needed, we can state that the introduction of clinical islet transplantation offers hope for type 1 diabetic patients.
AB - Introduction: The results of clinical islet transplantation in Japan are, here in, reported and discussed its efficacy and problems. Methods: Since the first islet transplantation was performed in 2004, 65 islet isolations and 34 islet transplantations to 18 type 1 diabetic patients have been performed in Japan. Results: Following islet transplantation, patients experienced decreased insulin requirements and lower hemoglobin A1C levels, and positive serum C-peptide levels. All patients achieved stabilized blood glucose levels and the disappearance of hypoglycemic unawareness. Although three patients achieved insulin independency for a limited period, persistent islet graft function was difficult to maintain. Overall islet graft survival was 86.5% at 6 months, 78.7% at 1 year, and 62.9% at 2 years after the first islet transplantation. In our institution, we carried out 23 islet isolations and six islet transplantations to four patients. Although insulin independency was not achieved, all patients showed a disappearance of hypoglycemic unawareness. Conclusions: Using data from the Japanese Trial of Islet Transplantation, the effectiveness of islet transplantation was shown even when using the pancreata from non-heart-beating donors. Although there are a number of problems to be solved and further improvement is needed, we can state that the introduction of clinical islet transplantation offers hope for type 1 diabetic patients.
UR - http://www.scopus.com/inward/record.url?scp=63649145065&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=63649145065&partnerID=8YFLogxK
U2 - 10.1007/s00534-008-0020-3
DO - 10.1007/s00534-008-0020-3
M3 - Article
C2 - 19165415
AN - SCOPUS:63649145065
SN - 0944-1166
VL - 16
SP - 124
EP - 130
JO - Journal of Hepato-Biliary-Pancreatic Surgery
JF - Journal of Hepato-Biliary-Pancreatic Surgery
IS - 2
ER -